Category: Global Stakeholder Communications

Ministry of Health of Ukraine Order 1528 for Public Release of Trial Results
Permalink Image
07 Jan, 2020

Ministry of Health of Ukraine Order 1528 for Public Release of Trial Results

By Nirpal Virdee, Global Head of Transparency & Disclosure  Over the past several years, Ukraine has taken significant steps with its healthcare services in hopes of matching the high quality, modern healthcare provided in leading western countries. The Ministry of Health (MoH) of Ukraine continues to invest heavily in this ambitious goal. New legislation in parliament in 2017 allowed for a ...

Read More
Health Canada PRCI Guiding Principles and Observations
Permalink Image
16 Sep, 2019

Health Canada PRCI Guiding Principles and Observations

Health Canada released guidance on March 12, 2019 pertaining to its Public Release of Clinical Information (PRCI) initiative. Health Canada’s objective with this initiative is to make anonymized clinical information in drug submissions and medical device applications publicly available for non-commercial purposes to enable re-analyses of data, foster new research questions, and help Canadians to m ...

Read More
Summary of Health Canada's Public Release of Clinical Information Initiative
Permalink Image
16 Sep, 2019

Summary of Health Canada’s Public Release of Clinical Information Initiative

Health Canada released guidance on March 12, 2019 pertaining to its Public Release of Clinical Information (PRCI) initiative. Health Canada’s objective with this initiative is to make anonymized clinical information in drug submissions and medical device applications publicly available for non-commercial purposes to enable re-analyses of data, foster new research questions, and help Canadians to m ...

Read More
FDA Seeking Feedback on Drug Approval Transparency and Disclosure Efforts
Permalink Image
09 Jul, 2019

FDA Seeking Feedback on Drug Approval Transparency and Disclosure Efforts

By Kristin McDougall, Workstream Lead, Transparency & Disclosure Background In 2018, the Food and Drug Administration (FDA) launched a pilot to test the capability of publicly posting summaries of the safety and efficacy information that is used to make drug approval decisions. This followed suit with the European Medicine Agency’s (EMA) Policy 0070 that launched in 2015 and Health Canada’s ...

Read More
EMA Policy 0070 External Guidance Update
Permalink Image
15 Nov, 2018

EMA Policy 0070 External Guidance Update

Even though the European Medicines Agency (EMA) has suspended publication of clinical data through Policy 0070 due to its Brexit business continuity plan, EMA posted a Policy 0070 external guidance update on November 11, 2018. Revision 4 is now in effect. Policy 0070 External Guidance Update - Major Changes Several major changes are noted in this “Summary of Changes” document, including: Cl ...

Read More
1 2 3 4